Table 2 Preoperative patient characteristics of pre-implementation and post-implementation groups
Characteristics | Pre-implementation n = 115 | Post-implementation n = 115 | p-value |
|---|---|---|---|
Age | |||
 Mean (SD) | 63.9 (10.27) | 64.6 (10.44) | 0.615 |
Sex: n(%) | |||
 Female | 75 (65.2) | 78 (67.8) | 0.675 |
 Male | 40 (34.8) | 37 (32.2) |  |
BMI | |||
 Mean (SD) | 28.89 (5.96) | 27.49 (5.57) | 0.068 |
ASA: n (%) | |||
 I | 25 (22.5) | 29 (25.2) | 0.732 |
 II | 52 (46.9) | 56 (48.7) |  |
 III | 34 (30.6) | 30 (26.1) |  |
Smoking status: n (%) | |||
 Non-smoker | 106 (92.2) | 106 (92.2) | > 0.999 |
Medical comorbidities: n(%) | |||
 Known diabetes mellitus | 5 (4.4) | 3 (2.6) | 0.722 |
 Coronary artery disease | 9 (7.8) | 9 (7.8) | > 0.999 |
 Respiratory disease | 24 (20.9) | 10 (8.7) | 0.015 |
 Anaemiaa | 12 (10.4) | 4 (3.5) | 0.067 |
 History of PONV | 35 (30.4) | 19 (16.7) | 0.014 |
 Chronic kidney injuryb | 4 (3.5) | 1 (0.9) | 0.175 |
QoR-15 score | |||
 Mean (SD) | 113.94 (17.85) | 115.70 (17.17) | 0.447 |
Worst NRS score mean: (SD) | |||
 Rest | 3.81 (2.73) | 3.58 (2.79) | 0.527 |
 Movement | 5.90 (2.47) | 5.92 (2.61) | 0.967 |
OME consumption (mg/day) | |||
 Median (Q1, Q3) | 0 (0, 0) | 0 (0, 0) | 0.626 |